Document Detail


One hundred pound weight losses with an intensive behavioral program: changes in risk factors in 118 patients with long-term follow-up.
MedLine Citation:
PMID:  17684198     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Treatment of severe obesity is difficult; in the past, lifestyle measures did not prove effective. Recently, however, intensive behavioral interventions using meal replacements and low-energy diets have enabled some severely obese persons to achieve nonobese weights. OBJECTIVE: We assessed rates of weight loss, changes in risk factors and medication requirements, and long-term weight maintenance in patients who lost >or=100 pounds (45.5 kg). DESIGN: Over a 9-y period, we prospectively identified patients who lost >or=100 pounds (45.5 kg) and actively recorded follow-up weights. Charts were systematically reviewed to assess outcome measures and side effects. The intervention included meal replacements (shakes and entrées), low-energy diets, weekly classes, and training in record keeping and physical activity. Assessments included weekly weights, laboratory studies, medication use, lifestyle behaviors, side effects, and follow-up weights. RESULTS: Sixty-three men and 55 women lost >or=100 pounds. At baseline, the subjects' average weight was 160 kg, 97% had >or=1 obesity-related comorbidity, and 74% were taking medications for comorbidities. Weight losses averaged 61 kg in 44 wk. Medications were discontinued in 66% of patients with a cost savings of $100/mo. Despite medication discontinuation, significant decreases in LDL cholesterol (20%), triacylglycerol (36%), glucose (17%), and systolic (13%) and diastolic (15%) blood pressure values were seen. Side effects were mild, and only 2 patients had severe or serious adverse events. At an average of 5 y of follow-up, patients were maintaining an average weight loss of 30 kg. CONCLUSION: Intensive behavioral intervention can be very effective with minimal risk for certain severely obese persons.
Authors:
James W Anderson; Shannon B Conley; Amy S Nicholas
Related Documents :
9504328 - Intermittent vs continuous vlcd therapy in obesity treatment.
17135618 - A randomized clinical trial testing treatment preference and two dietary options in beh...
20222968 - Efficacy of a meal replacement diet plan compared to a food-based diet plan after a per...
8363198 - Treatment of obesity by moderate and severe caloric restriction. results of clinical re...
16462118 - A new diagnostic indicator using concanavalin a low-affinity lactoferrin levels in mamm...
23497878 - The influence of goishi tea on adipocytokines in obese mice.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  The American journal of clinical nutrition     Volume:  86     ISSN:  0002-9165     ISO Abbreviation:  Am. J. Clin. Nutr.     Publication Date:  2007 Aug 
Date Detail:
Created Date:  2007-08-08     Completed Date:  2007-09-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376027     Medline TA:  Am J Clin Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  301-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Internal Medicine, College of Medicine, and the Health Management Resources Weight Management Program, University of Kentucky, Lexington, KY 40502-0298, USA. jwandersmd@aol.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Behavior Therapy*
Body Mass Index
Comorbidity
Female
Follow-Up Studies
Humans
Male
Middle Aged
Obesity, Morbid / diet therapy,  epidemiology,  psychology*,  therapy
Patient Selection
Retrospective Studies
Risk Factors
Time Factors
Treatment Outcome
Weight Loss

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver di...
Next Document:  Methylphenidate reduces energy intake and dietary fat intake in adults: a mechanism of reduced reinf...